A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions

A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions

There are increasing demands for informative cancer biomarkers, accessible via minimally invasive procedures, both for initial diagnostics and to follow‐up personalized cancer therapy. Fine‐needle aspiration (FNA) biopsy provides ready access to relevant tissues; however, the minute sample amounts r...

Full description

Bibliographic Details
Main Authors: Bo Franzén, Masood Kamali‐Moghaddam, Andrey Alexeyenko, Thomas Hatschek, Susanne Becker, Lotta Wik, Jonas Kierkegaard, Annika Eriksson, Naveen R. Muppani, Gert Auer, Ulf Landegren, Rolf Lewensohn
Format: Article
Language:English
Published: Wiley 2018-09-01
Series:Molecular Oncology
Subjects:
breast cancer diagnosis
fine‐needle aspiration
protein biomarker
proximity extension assay
Online Access:https://doi.org/10.1002/1878-0261.12350

Internet

https://doi.org/10.1002/1878-0261.12350

Similar Items